Clinical Trial Update: Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

View source ↗

Summary

A real-world clinical trial entry describing outcomes of the aflibercept biosimilar MY-1701P for exudative age-related macular degeneration, currently in recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• MY-1701P (aflibercept)

Snippet

Sponsor: Saglik Bilimleri Universitesi | Conditions: Age Related Macular Degeneration, Exudative Age-Related Macular Degeneration | Status: RECRUITING